<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37243803</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Neurological and endocrinological involvement in neonatal lupus erythematosus: a retrospective study at a tertiary hospital in Eastern China.</ArticleTitle><Pagination><StartPage>2461</StartPage><EndPage>2468</EndPage><MedlinePgn>2461-2468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06622-8</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Neonatal lupus erythematosus (NLE) is a rare autoimmune disease that causes transient impairment of multi-organ functions and is mainly caused by maternally transmitted antibodies.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to investigate the clinical features of infants with NLE, focusing on the presence of neurological and endocrinological involvement.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The clinical data of infants diagnosed with NLE at the Children's Hospital of Soochow University from 2011 to 2022 were collected and retrospectively analyzed.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">In all, 39 patients with NLE were included, and the most common symptom was rash, followed by hematological, hepatic, cardiac, gastrointestinal, neurological, and endocrine symptoms. Among the 10 patients with neurological impairment, intracranial hemorrhage was the most common, followed by convulsions, hydrocephalus, extracerebral space enlargement, and aseptic meningitis. All patients with neurological impairment were positive for anti-SSA/Ro antibodies. Five of these patients were double positive for anti-SSA/Ro and anti-SSB/La antibodies. All 10 patients had multi-organ system involvement, with hematological involvement being the most common, and three patients had varying degrees of developmental delay at the post-discharge follow-up. Nine patients with endocrine impairment were positive for anti-SSA/Ro antibodies, with pancreatic impairment being the most common. There were four cases of hyperinsulinemia and hypoglycemia, one case of diabetes mellitus with ketoacidosis, two cases of hypothyroidism, one case of hypoadrenocorticism, and one case of lysinuric protein intolerance, all of which were normalized before discharge. All patients with endocrine impairment showed hematological involvement, and some showed feeding intolerance as their first symptom. One patient had abnormal liver function at post-discharge follow-up, and two patients had a rash caused by a severe allergy to milk protein.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">At our hospital, no significant gender differences were observed in the occurrence of NLE, and a predominance of skin, blood, liver, and heart involvement was observed. Patients with multiple central nervous system injuries and organ involvement are more likely to have growth retardation. Endocrine disorders are transient in NLE patients, and some showed feeding intolerance as the first manifestation. Key Points &#x2022;A retrospective investigation of the clinical characteristics and prognosis of 39 NLE patients was performed, focusing on the clinical features of patients with neurological and endocrine system involvement to improve clinicians' understanding of this disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Wenqiang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ding</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengzhao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Changchang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zihao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xueping</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3502-7655</Identifier><AffiliationInfo><Affiliation>Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China. zhuxueping4637@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81971423</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82271741</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>BE2020658</GrantID><Agency>Jiangsu Province's Key Provincial Talents Program</Agency><Country/></Grant><Grant><GrantID>ZD2021013</GrantID><Agency>Jiangsu Provincial Commission of Health and Family Planning</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C536397">Neonatal Systemic lupus erythematosus</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005076" MajorTopicYN="Y">Exanthema</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004703" MajorTopicYN="N">Endocrine System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endocrine</Keyword><Keyword MajorTopicYN="N">Feeding intolerance</Keyword><Keyword MajorTopicYN="N">Growth retardation</Keyword><Keyword MajorTopicYN="N">Lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Neonatal</Keyword><Keyword MajorTopicYN="N">Neurological</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>15</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37243803</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06622-8</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06622-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yokogawa N, Sumitomo N, Miura M, Shibuya K, Nagai H, Goto M et al (2017) Neonatal lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 40:124&#x2013;130. https://doi.org/10.2177/jsci.40.124</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.40.124</ArticleId><ArticleId IdType="pubmed">28603203</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YQ, Wang Q, Luo Y, Zhao Y (2015) Neonatal lupus erythematosus: a review of 123 cases in China. Int J Rheum Dis 18:761&#x2013;767. https://doi.org/10.1111/1756-185X.12652</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12652</ArticleId><ArticleId IdType="pubmed">26171790</ArticleId></ArticleIdList></Reference><Reference><Citation>Erden A, Fanouriakis A, Kilic L, Sari A, Armagan B, Bilgin E et al (2020) Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients&#x2019; data. Turk J Med Sci 50:281&#x2013;290. https://doi.org/10.3906/sag-1910-39</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1910-39</ArticleId><ArticleId IdType="pubmed">31905489</ArticleId><ArticleId IdType="pmc">7164747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LA, Sokol RJ, Buyon JP (2002) Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 109:E11. https://doi.org/10.1542/peds.109.1.e11</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.1.e11</ArticleId><ArticleId IdType="pubmed">11773579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LA (2005) Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev 4:207&#x2013;213. https://doi.org/10.1016/j.autrev.2004.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2004.11.003</ArticleId><ArticleId IdType="pubmed">15893713</ArticleId></ArticleIdList></Reference><Reference><Citation>McCuistion CH, Schoch EJ (1954) Possible discoid lupus erythematosus in newborn infant; report of a case with subsequent development of acute systemic lupus erythematosus in mother. AMA Arch Derm Syphilol 70:782&#x2013;785</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archderm.1954.01540240088009</ArticleId><ArticleId IdType="pubmed">13206423</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al (1998) Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658&#x2013;1666. https://doi.org/10.1016/s0735-1097(98)00161-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(98)00161-2</ArticleId><ArticleId IdType="pubmed">9626848</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN (2011) Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 20:1187&#x2013;1192. https://doi.org/10.1177/0961203311412096</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311412096</ArticleId><ArticleId IdType="pubmed">21768176</ArticleId></ArticleIdList></Reference><Reference><Citation>Heelan K, Watson R, Collins SM (2013) Neonatal lupus syndrome associated with ribonucleoprotein antibodies. Pediatr Dermatol 30:416&#x2013;423. https://doi.org/10.1111/pde.12088</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pde.12088</ArticleId><ArticleId IdType="pubmed">23432184</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahian M, Khosravi A, Anbardar MH (2011) Early cholestasis in neonatal lupus erythematosus. Ann Saudi Med 31:80&#x2013;82. https://doi.org/10.4103/0256-4947.70569</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0256-4947.70569</ArticleId><ArticleId IdType="pubmed">20864789</ArticleId><ArticleId IdType="pmc">3101731</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP (1996) Neonatal lupus: bedside to bench and back. Scand J Rheumatol 25:271&#x2013;276. https://doi.org/10.3109/03009749609104057</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009749609104057</ArticleId><ArticleId IdType="pubmed">8921918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP et al (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832&#x2013;1835. https://doi.org/10.1002/1529-0131(200108)44:8%3c1832:AID-ART320%3e3.0.CO;2-C</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200108)44:8&lt;1832:AID-ART320&gt;3.0.CO;2-C</ArticleId><ArticleId IdType="pubmed">11508435</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Frias J, Badri T (2022) Neonatal Lupus Erythematosus. StatPearls Publishing, In StatPearls</Citation></Reference><Reference><Citation>Silverman E, Jaeggi E (2010) Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 72:223&#x2013;225. https://doi.org/10.1111/j.1365-3083.2010.02443.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2010.02443.x</ArticleId><ArticleId IdType="pubmed">20696019</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagawa S (2005) Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients. J Dermatol 32:514&#x2013;522. https://doi.org/10.1111/j.1346-8138.2005.tb00793.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1346-8138.2005.tb00793.x</ArticleId><ArticleId IdType="pubmed">16335866</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque K, Morel N, Maltret A, Baron G, Masseau A, Orquevaux P et al (2015) Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. Autoimmun Rev 14:1154&#x2013;1160. https://doi.org/10.1016/j.autrev.2015.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.08.005</ArticleId><ArticleId IdType="pubmed">26284740</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel T, Kitcharoensakkul M, Fotis L, Baszis K (2014) The heart and pediatric rheumatology. Rheum Dis Clin North Am 40:61&#x2013;85. https://doi.org/10.1016/j.rdc.2013.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2013.10.008</ArticleId><ArticleId IdType="pubmed">24268010</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Kim MY, Llanos C, Le PU, Guerra MM, Askanase AD et al (2010) Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69:1827&#x2013;1830. https://doi.org/10.1136/ard.2009.119263</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.119263</ArticleId><ArticleId IdType="pubmed">20447951</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542&#x2013;1548. https://doi.org/10.1161/01.CIR.0000142046.58632.3A</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000142046.58632.3A</ArticleId><ArticleId IdType="pubmed">15353508</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhiannon JJ (2008) Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management. Clin Rev Allergy Immunol 34:356&#x2013;360. https://doi.org/10.1007/s12016-007-8052-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-007-8052-z</ArticleId><ArticleId IdType="pubmed">18181036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liszewska A, Wozniacka A (2022) Neonatal lupus erythematosus - prevention is better than cure. Postepy Dermatol Alergol 39:1021&#x2013;1026. https://doi.org/10.5114/ada.2022.122601</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ada.2022.122601</ArticleId><ArticleId IdType="pubmed">36686025</ArticleId><ArticleId IdType="pmc">9837598</ArticleId></ArticleIdList></Reference><Reference><Citation>Elefante E, Bond M, Monti S, Lepri G, Cavallaro E, Felicetti M et al (2018) One year in review 2018: systemic vasculitis. Clin Exp Rheumatol 36(Suppl 111):12&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">29799395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Yuan D, Tan G (2019) Neurological Involvement in Primary Systemic Vasculitis. Front Neurol 10:430. https://doi.org/10.3389/fneur.2019.00430</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00430</ArticleId><ArticleId IdType="pubmed">31105641</ArticleId><ArticleId IdType="pmc">6498988</ArticleId></ArticleIdList></Reference><Reference><Citation>Boros CA, Spence D, Blaser S, Silverman ED (2007) Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus. Arthritis Rheum 57:261&#x2013;266. https://doi.org/10.1002/art.22543</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22543</ArticleId><ArticleId IdType="pubmed">17330304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisuthsarewong W, Soongswang J, Chantorn R (2011) Neonatal lupus erythematosus: clinical character, investigation, and outcome. Pediatr Dermatol 28:115&#x2013;121. https://doi.org/10.1111/j.1525-1470.2011.01300.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1470.2011.01300.x</ArticleId><ArticleId IdType="pubmed">21362029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25&#x2013;33. https://doi.org/10.1016/j.jaut.2013.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.01.008</ArticleId><ArticleId IdType="pubmed">23395425</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz C, Isenberg DA (2019) Review of major endocrine abnormalities in patients with systemic lupus erythematosus. Clin Exp Rheumatol 37:791&#x2013;796</Citation><ArticleIdList><ArticleId IdType="pubmed">31172923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashmi SB, Ahmed S (2022) Children with lysinuric protein intolerance: Experience from a lower middle income country. World J Clin Pediatr 11:369&#x2013;374. https://doi.org/10.5409/wjcp.v11.i4.369</Citation><ArticleIdList><ArticleId IdType="doi">10.5409/wjcp.v11.i4.369</ArticleId><ArticleId IdType="pubmed">36052112</ArticleId><ArticleId IdType="pmc">9331405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>